The effects of low level laser radiation on bacterial growth |
Chung, Wendy
(Department of Physical Therapy, Azusa Pacific University)
Petrofsky, Jerrold S. (Department of Physical Therapy, Loma Linda University) Laymon, Michael (School of Physical Therapy, Touro University) Logoluso, Jason (Department of Physical Therapy, Azusa Pacific University) Park, Joon (Department of Physical Therapy, Azusa Pacific University) Lee, Judy (Department of Physical Therapy, Azusa Pacific University) Lee, Haneul (Department of Physical Therapy, Loma Linda University) |
1 | Mulcahy D, McCormack D, McElwain J, Wagstaff S, Conroy C. Low level laser therapy: a prospective double blind trial of its use in an orthopaedic population. Injury 1995;26:315-7. DOI ScienceOn |
2 | Flemming K, Cullum N. Laser therapy for the treatment of venous leg ulcers. J Tissue Viability 1999;9:67. DOI ScienceOn |
3 | Lucas C, van Gemert MJ, de Haan RJ. Efficacy of low-level laser therapy in the management of stage III decubitus ulcers: a prospective, observer-blinded multicentre randomised clinical trial. Lasers Med Sci 2003;18:72-7. DOI ScienceOn |
4 | U.S. Food and Drug Administration. Summary of Safety and Effectiveness. 510(k) Summary Microlight 830 Laser. Silver Spring: U.S. Food and Drug Administration, 2002. |
5 | Saltmarche AE. Low level laser therapy for healing acute and chronic wounds-the extendicare experience. Int Wound J 2008;5:351-60. DOI ScienceOn |
6 | Nussbaum EL, Lilge L, Mazzulli T. Effects of 810 nm laser irradiation on in vitro growth of bacteria: comparison of continuous wave and frequency modulated light. Lasers Surg Med 2002;31:343-51. DOI ScienceOn |
7 | Nussbaum EL, Lilge L, Mazzulli T. Effects of 630-, 660-, 810-, and 905-nm laser irradiation delivering radiant exposure of 1-50 J/cm2 on three species of bacteria in vitro. J Clin Laser Med Surg 2002;20:325-33. DOI ScienceOn |
8 | U.S. Food and Drug Administration. Summary of Safety and Effectiveness. 510(k) Summary-Acculaser Pro Low Loevel Laser Therapy. Silver Spring: U.S. Food and Drug Administration, 2002. |
9 | Summary of Safety and Effectiveness. 510(k) Summary-TUGO Erchonia PL2002. 2002. |
10 | Sears FW, Young HD. Young sears. In: Sears FW, Zemansky MW, Young HD, editors. University physics. 5th ed. Reading (MA): Addison-Wesley Pub. Co.; 1976. |
11 | Rosencwaig A, Pines E. A photoacoustic study of newborn rat stratum corneum. Biochim Biophys Acta 1977;493:10-23. DOI ScienceOn |
12 | Basford JR. Low-energy laser therapy: controversies and new research findings. Lasers Surg Med 1989;9:1-5. |
13 | Naeser MA, Hahn KA, Lieberman BE, Branco KF. Carpal tunnel syndrome pain treated with low-level laser and microamperes transcutaneous electric nerve stimulation: A controlled study. Arch Phys Med Rehabil 2002;83:978-88. DOI ScienceOn |
14 | Gamaleya NF. Laser biomedical research in USSR. Laser Appl Med Biol 1977;1:1-173. |
15 | Gam AN, Thorsen H, Lønnberg F. The effect of low-level laser therapy on musculoskeletal pain: a meta-analysis. Pain 1993;52:63-6. DOI ScienceOn |
16 | Fontana CR, Kurachi C, Mendonça CR, Bagnato VS. Temperature variation at soft periodontal and rat bone tissues during a medium-power diode laser exposure. Photomed Laser Surg 2004;22: 519-22. DOI ScienceOn |
17 | Irvine J, Chong SL, Amirjani N, Chan KM. Double-blind randomized controlled trial of low-level laser therapy in carpal tunnel syndrome. Muscle Nerve 2004;30:182-7. DOI ScienceOn |
18 | Kujawa J, Zavodnik L, Zavodnik I, Bryszewska M. Low-intensity near-infrared laser radiation-induced changes of acetylcholinesterase activity of human erythrocytes. J Clin Laser Med Surg 2003;21:351-5. DOI |
19 | FDA. Summary of Safety and Effectiveness. 510(k) Summary - AcculaserTM Pro4. 2004. |
20 | Wang HW, Zhu TC, Putt ME, Solonenko M, Metz J, Dimofte A, et al. Broadband reflectance measurements of light penetration, blood oxygenation, hemoglobin concentration, and drug concentration in human intraperitoneal tissues before and after photodynamic therapy. J Biomed Opt 2005;10:14004. DOI ScienceOn |
21 | FDA. Summary of Safety and Effectiveness. 510(k) Summary - BioFlex Professional Therapy Systems. 2003. |
22 | FDA. Warning Letter: FLA-06-08. Department of Health and Human Services. 2005. |
23 | van Gemert MJ, Jacques SL, Sterenborg HJ, Star WM. Skin optics. IEEE Trans Biomed Eng 1989;36:1146-54. DOI ScienceOn |